Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
companies in this sector in the United States:
sales of $53.65 billion
of which 62%
was Operating Segment-Global Innovative Phar),
of which 42%
was Pharmaceuticals & Biological Products), and
of which 66%
was Innovative Medicines).
Roche Holding Aktiengesellschaft reported sales of $58.19 billion
December of 2018.
increase of 7.0%
versus 2017, when the company's sales were $54.36 billion.
This was the third consecutive year of growth at Roche Holding Aktiengesellschaft.
Sales of Pharmaceuticals saw an increase
7.1% in 2018, from
$42.04 billion to $45.01 billion.